Evidence map›Paper›PMID 18253729›Full record

ArticleImmunogenetics2008

Variable responses of formyl peptide receptor haplotypes toward bacterial peptides.

Jeannie M Gripentrog, John S Mills, George J Saari, Heini M Miettinen

Open access · bronzeAbstract read
In one paragraph

Article in Immunogenetics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. TheFrontiers in immunology · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jeannie M GripentrogDepartment of Microbiology, Montana State University, MT 59717, USA.
John S Mills
George J Saari
Heini M Miettinen
Montana State University · USBozeman Health Deaconess Hospital · US

Funding

UNDERGRADUATE RESEARCH AND TRAININGP20RR016464 · NCRR · UNIVERSITY OF NEVADA RENO · PI REIBER, CARL · 2001 to 2011
$30.3M
Mechanisms of chemoattractant receptor regulationR01AI051726 · NIAID · MONTANA STATE UNIVERSITY (BOZEMAN) · PI MIETTINEN, HEINI MARITA · 2002 to 2005
$991k
Effects of Formyl Peptide Receptor variants on functionR21DE016114 · NIDCR · MONTANA STATE UNIVERSITY (BOZEMAN) · PI MILLS, JOHN S · 2004 to 2005
$389k
NCRR NIH HHS P20 RR-016464NCRR NIH HHS P20 RR016464NIAID NIH HHS R01 AI051726NIAID NIH HHS R01 AI51726NIDCR NIH HHS R21 DE016114NIDCR NIH HHS R21DE16114
6 · The paper itself

Abstract

The chemoattractant neutrophil formyl peptide receptor (FPR) binds bacterial and mitochondrial N-formylated peptides, which allows the neutrophils to find the bacterial source and/or site of tissue damage. Certain inflammatory disorders may be due in part to an impaired innate immune system that does not respond to acute bacterial damage in a timely fashion. Because the human FPR is encoded by a large number of different haplotypes arising from ten single-nucleotide polymorphisms, we examined the possibility that some of these haplotypes are functionally distinct. We analyzed the response of three common FPR haplotypes to peptides from Escherichia coli, Mycobacterium avium ssp. paratuberculosis, and human mitochondria. All three haplotypes responded similarly to the E. coli and mitochondrial peptides, whereas one required a higher concentration of the M. avium peptide fMFEDAVAWF for receptor downregulation, receptor signaling, and chemotaxis. This raises the possibility of additional bacterial species differences in functional responses among FPR variants and establishes a precedent with potentially important implications for our innate immune response against bacterial infections. We also investigated whether certain FPR haplotypes are associated with rheumatoid arthritis (RA) by sequencing FPR1 from 148 Caucasian individuals. The results suggested that FPR haplotypes do not significantly contribute toward RA.

Indexed as

AdolescentAdultAgedAged, 80 and overAmino Acid SequenceAnimalsArthritis, RheumatoidChemotactic FactorsCHO CellsCricetinaeCricetulusEscherichia coliFemaleFluorescent Antibody TechniqueGenotypeHaplotypesChemotactic FactorsMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Peptide FragmentsReceptors, Formyl Peptide

Identifiers

PMID18253729
PMCPMC2435592
OpenAlexW1978614602

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.